STADA Arzneimittel AG
STADA Arzneimittel AG informs about receipt of binding, conditional take-over offer
STADA Arzneimittel AG / Key word(s): Miscellaneous 23-Feb-2017 / 14:55 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bad Vilbel, February 23, 2017 - STADA Arzneimittel AG informs that it has received today a legally binding offer from Advent International Corporation regarding a bid for the acquisition of up to 100 percent of the shares in the Company at a takeover price of Euro 58.00 per STADA share in cash plus dividend 2016 (dividend payment 2015 amounted to Euro 0.70 per share). The offer is limited until Monday, February 27, 2017, and subject to the approval of the Company's Executive Board. In close cooperation with the Supervisory Board, the Executive Board will review the offer in the best interest of the Company and will continue the open-minded talks with all interested parties to evaluate further value- enhancing potential, the value of strategic concepts, and to secure the interests of all stakeholders. STADA will keep both the capital markets and the public updated on tangible development in this regard, in line with the applicable legal requirements. Contact: STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2- 18 / 61118 Bad Vilbel - Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: leslie.iltgen@stada.de Or visit us in the Internet at www.stada.com. --------------------------------------------------------------------------- 23-Feb-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News Service
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden